Sanofi reports positive results from nirsevimab in infants with RSV

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorised blue). Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH).



  • nirsevimab